Anne Traynor, MD
Enriched profileAssociate professor (CHS), Hematology, Medical Oncology and Palliative Care · University of Wisconsin–Madison
Anne Traynor is Associate professor (CHS), Hematology, Medical Oncology and Palliative Care at University of Wisconsin–Madison. OpenAlex indexes 162 publications with 4,338 citations (h-index 38); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 24 Oct 2026
Anne Traynor, MD, is Associate professor (CHS), Hematology, Medical Oncology and Palliative Care at University of Wisconsin–Madison. The public record shows 162 publications with 4,338 citations (h-index 38), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 1 companies, 6 NIH-funded awards (2003–2022).
- Top research focus: Lung Cancer Treatments and Mutations
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 24 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 70.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 24 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Expanded Access to Ensartinib for Participants With ALK+ NSCLC
Sponsor: Xcovery Holdings, Inc.
Industry payments
Updated 24 Oct 2026
1 company reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Astellas Pharma US IncProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor100%Tagrisso100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 24 Oct 2026
6 NIH research awards on record, funded 2003–2022 per NIH RePORTER. The latest:
- National Clinical Trials Network Research at the University of Wisconsin
University of Wisconsin-Madison
FY2021$599,319UG1CA233277
Congress activity
Updated 24 Oct 2026
46 congress contributions (2004–2023) across AACR, ASCO, ASTRO per OpenAlex. The most recent:
- Dares: A phase II trial of durvalumab and ablative radiation in extensive stage small cell lung cancer.
ASCO Annual Meeting
ASCO2023Co-authorPosterTrials in progress - Genomic comparison of MET exon 14 skipping and MET amplified non-small cell lung cancer.
ASCO Annual Meeting
ASCO2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Most-cited works
by citation count (OpenAlex)Network
Updated 24 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 24 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
medicine.wisc.edu/news/successful-patient-outcome-lung-cancer-clinical-trial
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗ - Other
wwwtest.cancer.wisc.edu/research/event/uwccc-grand-rounds-2017-09-13-2017-09-27-2017-10-25
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wwwtest.cancer.wisc.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 24 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →zocdoc.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →zocdoc.com ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.wisc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Justine Bruce, MD
University of Wisconsin–Madison
Mark Albertini, MD
University of Wisconsin–Madison
Bryn Webb, MD
University of Wisconsin–Madison
Jeannina Smith, MD
University of Wisconsin–Madison
Pasi Janne, MD, PhD
Dana-Farber Cancer Institute
Julie Brahmer, MD
Johns Hopkins University School of Medicine
Enriqueta Felip, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center